A lecturer of the Faculty of Allied Health Sciences, Chula unveils her research on high egg white protein dietary supplement Albupro Plus, functional food for health lovers, now ready for sale.
Among older adults with advanced chronic kidney disease, mental and physical health-related quality of life worsened in the year before they started dialysis treatment, but their quality of life stabilized after dialysis was initiated.
New research from VCU Massey Cancer Center — published Thursday in Cell Reports — demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.
• Kidney transplant recipients typically take the immunosuppressant drug tacrolimus to prevent rejection, and some patients experience large fluctuations in blood levels of tacrolimus even when the dose is unchanged.
• In a recent study, pediatric kidney transplant recipients with such variability had higher risks of developing antibodies against the transplanted kidney, putting them at risk of rejection.
Scientists have developed a cheap, convenient smartphone test for monitoring patients at risk for dangerous blood clots. Research demonstrating that this test works, along with a second study on using artificial intelligence (AI) to improve testing and treatment for people with kidney stones, will be presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. Both studies could help resolve longstanding challenges in healthcare and laboratory testing.
New research shows that removing a race modifier from a formula used to diagnose kidney disease could lead to more equitable care for Black patients. This study and a second that examines how this same diagnostic approach impacts Asian patients will be presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.
Compared with atorvastatin, rosuvastatin was associated with an 8% higher risk of hematuria (blood in the urine), a 17% higher risk of proteinuria (protein in the urine), and a 15% higher risk of developing kidney failure requiring replacement therapy such as dialysis or transplantation.
Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.
New research indicates that the polycystin-2 protein in cells’ endoplasmic reticulum is important for maintaining kidney health, and its lack can contribute to autosomal dominant polycystic kidney disease.
Scientists are trying to improve their understanding of the development of clear cell renal cell carcinoma to develop new targeted therapeutics. In a new study published in European Urology, Moffitt Cancer Center researchers identify biomarkers for this disease type and develop a tool to indicate which patients are at high risk of poor outcomes based on their biomarker expression.
Researchers have solved a medical mystery in a poorly understood disease by uncovering which cells cause tumours in patients with tuberous sclerosis complex (TSC).
Hackensack Meridian Hackensack University Medical Center’s Department of Urology presented 26 abstracts at the American Urological Association’s (AUA) 2022 Annual Meeting, held in New Orleans, LA, from May 13-16, 2022.
A new study from UH Harrington Heart & Vascular Institute in Cleveland further proves that people living in areas that were subjected to housing discrimination decades ago now suffer from higher rates of poor health outcomes, including heart disease, kidney failure and diabetes.
A cross sectional study found that substantial discrepancies exist between individual estimated glomerular filtration rate (eGFR) and directly measured GFR (mGFR). Laboratory reports that provide eGFR calculations should consider including the distribution of this uncertainty. According to the authors, renaming the eGFR as a population average GFR (or paGFR) merits further discussion. The findings are published in Annals of Internal Medicine.
Noninvasive (stage Ta) bladder cancers with "high-grade" characteristics should be considered at high risk of recurrence, concludes a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
KidneyCure (the ASN Foundation) is honored to continue its support of investigators committed to advancing kidney health. Building on decades of success, KidneyCure makes it possible to improve knowledge and treatment by identifying and funding high-impact projects.
New research in rats finds a diet high in the fiber inulin offered a protective effect against the damage of a high-salt diet. The research will be presented this week at the American Physiological Society and American Society for Nephrology Control of Renal Function in Health and Disease conference
New research in mice finds that time-restricted feeding improves markers of kidney and vascular health. The research will be presented this week at the American Physiological Society and American Society for Nephrology Control of Renal Function in Health and Disease conference.
Vitamin D supplementation may help offset damaging bone loss that occurs in some people who take canagliflozin, a commonly prescribed diabetes drug. Researchers will present their work this week at the American Physiological Society (APS) and American Society for Nephrology Control of Renal Function in Health and Disease conference in Charlottesville, Virginia.
A history of kidney problems may put people at a higher risk for impaired blood vessel function, which could lead to high blood pressure, preterm labor and other adverse outcomes, according to the results of a study in rats. The researchers will present their work this week at the American Physiological Society (APS) and American Society for Nephrology Control of Renal Function in Health and Disease conference in Charlottesville, Virginia.
Kidney researchers will meet next week to discuss a wide range of topics including circadian regulation of kidney function and blood pressure, renal consequences of obesity and kidney crosstalk with other organs at the American Physiological Society (APS) and American Society for Nephrology (ASN) Control of Renal Function in Health and Disease conference. The conference will be held June 26–30 in Charlottesville, Virginia.
In an analysis of data on US patients with autosomal dominant polycystic kidney disease, patient outcomes such as age of onset of kidney failure and access to kidney transplantation were strongly associated with race and ethnicity.
Afzal A. Siddiqui, Ph.D., director of the Center for Tropical Medicine and Infectious Disease and chair of the Department of Immunology and Molecular Microbiology at the Texas Tech University Health Sciences Center School of Medicine, began his quest to develop a schistosomiasis vaccine in 1991. With funding from the National Institutes of Allergies and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) and the Thrasher Foundation, he began conducting bench studies and pre-clinical development of what was known as the Sm-p80/GLA-SE schistosomiasis vaccine, which would eventually be branded SchistoShield®.
A new thulium fiber laser system may provide improved outcomes in the treatment of urinary stones for pediatric patients, compared to the current standard for laser lithotripsy, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
A recent study examined how uncertainty surrounding the evolving COVID-19 pandemic influenced shared decision-making between clinicians, older patients with chronic kidney disease, and their care partners.
The team of UC Santa Barbara biochemist Thomas Weimbs published the results of a clinical study that gives the first indication that ketogenic diets may be safe and effective in patients with polycystic kidney disease (PKD).
Cedars-Sinai clinicians and scientists, including anti-rejection therapy pioneer Stanley Jordan, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 4-8, 2022, in Boston. The ATC is the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.
A recent study by Johns Hopkins Medicine researchers has revealed that consuming at least one cup of coffee a day may reduce the risk of acute kidney injury (AKI) when compared to those who do not drink coffee.
In a study of individuals on hemodialysis who tested positive for SARS-CoV-2, most had a mild course of COVID-19, but 39%were hospitalized and 13% died.
Cells produce proteins like little factories. But if they make too much at the wrong times it can lead to diseases like cancer, so they control production with a process called RNA interference (RNAi).
• Although clinical trials have linked diabetes medications called sodium glucose transport-2 inhibitors to higher bone fracture risks, a large study found no additional risks when the medications were compared with diabetes drugs not associated with fractures.
• The findings applied to older adults with normal kidney function as well as to those with mild or moderate kidney disease.
Researchers at Saint Louis University School of Medicine are enrolling volunteers in an investigational drug trial for hypogonadal men with chronic kidney disease.
The American Society of Nephrology (ASN) is calling on kidney health professionals to take action to address the impact of climate change on the 850 million people—including more than 37 million Americans—living with kidney diseases across the world who are uniquely vulnerable to the effects of climate change.
New research from Ann & Robert H. Lurie Children’s Hospital of Chicago and collaborators from other institutions provides insights into some of the genetic characteristics resulting in the development of relapse in patients with Wilms tumor (nephroblastoma), the most common type of pediatric cancer of the kidney.
2011 changes in policies and recommendations related to the use of erythropoietin-stimulating agents were associated with lower hemoglobin levels and lower risks of major adverse cardiovascular events, mortality, and stroke among adults receiving hemodialysis, but with a higher risk of heart attack.
Hackensack University Medical Center surgeon performs kidney donor procedure using a single-incision laparoscopic approach — marking the first time the surgical technique has been used at the hospital.
Anyone who is taking a diuretic and a renin-angiotensin system (RSA) inhibitor for high blood pressure should be cautious about also taking ibuprofen, according to new research.
Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.